Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × kalinox × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Cytarabine 801 Cyclophosphamide 791 fludarabine 451 venetoclax 419 fludarabine phosphate 415 Azacitidine 402 Rituximab 378 Methotrexate 354 Etoposide 290 Filgrastim 262 Busulfan 250 Vincristine 244 Dexamethasone 244 Daunorubicin 244 Peripheral Blood Stem Cell Transplantation 219 Whole-Body Irradiation 211 Decitabine 206 Mycophenolic Acid 201 Granulocyte Colony-Stimulating Factor 183 Imatinib Mesylate 181 Idarubicin 181 Tacrolimus 179 Melphalan 179 Cyclosporine 162 Doxorubicin 157 Radiotherapy 154 Mitoxantrone 147 Prednisone 139 Lenalidomide 139 Dasatinib 135

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03483194 2020-06-23

REVEH

Weprom

Phase 2/3 Completed

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡